Call for Abstracts

ACR 2017 Abstract Submission Now ClosedCall for Abstracts


  • Select oral abstracts will be featured during education sessions
  • Gold Merit Award winners can win up to $400

View Abstracts btn

View 2016 abstracts »
View 2016 Gold Merit Award Recipients »

Why Submit

All radiologists, ACR members and nonmembers are invited to submit abstracts for presentation at ACR 2017, the third annual meeting of the American College of Radiology (ACR), May 21–25, 2016, in Washington, DC. 

Abstract presentation at ACR 2017 provides authors a unique opportunity to showcase their latest findings to the brightest in radiology, gain recognition from peers and top leaders, and receive valuable feedback to aid in future research. 

Types of Abstract Presentations

ePoster Presentations: Accepted abstracts will be selected and grouped together by a common theme and presented in electronic ePoster sessions available through kiosks at the meeting and online after the meeting.

ALL NEW! Oral Presentations: Authors of select high-quality abstracts will be invited to give 8–10 minute presentations during corresponding continuing education sessions. Oral presentations allow authors to showcase their work to a larger target audience. The first author must select this opportunity during the abstract submission process. 


Key Dates

Dates are tentative and subject to change.

Abstract submission site opens  September 12, 2016 
Abstract submission deadline  December 16, 2016* 
Deadline to modify abstracts  December 16, 2016* 
Disposition notifications sent to first author  January 27, 2017
Withdrawal deadline of accepted abstracts  April 3, 2017 
RFS Annual Meeting  May 20–21, 2017  
ACR 2017  May 21–25, 2017 

*submissions must be complete by 5pm ET 

General Information

  • QUALIFICATIONS: The abstract submission site is open to all trainees, young physicians, radiologists, medical physicists, radiation oncologists and representatives from other professions related to the subject categories listed below  
  • DEADLINE: Abstract submission ends at 5pm ET, Friday, December 16
  • ABSTRACT TYPE: Accepted abstracts will be presented in an ePoster format (electronic PowerPoint). No printed poster boards will be on display. Select abstract authors will be invited to give an 8–10 minute presentation during an educational session on a related topic.
    • Submission of an abstract constitutes a commitment by the first author to attend the annual meeting and address attendee questions if the abstract is accepted
    • Abstracts must be submitted online through the abstract submission site
    • Abstract submissions with an “incomplete” status cannot be processed
    • Abstracts must be based on original, completed research projects — not previously published or presented at other meetings; promissory research projects and case reports will not be considered
    • Abstracts must be formatted and organized into the following four sections: 1) Purpose, 2) Methods/Materials, 3) Results and 4) Conclusions
    • Abstract submissions are limited to 2,200 characters (total of all sections including Purpose, Materials/Methods, Results and Conclusions), 1 image and 1 table. Spaces count toward character limit.
    • Abstracts must be balanced and contain no commercial promotional content. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract.
    • An abstract may only be submitted once; duplicate abstracts (reporting the same data) that are submitted under a different title or author will not be considered
    • Abstracts must be proofread carefully to avoid errors before they are submitted. The ACR is not authorized to make changes to a submission. This includes typographical errors to the abstract title or text as well as additions or deletions of author names. Your abstract, if selected, will be published exactly as submitted. 
  • NOTIFICATIONS: Disposition notifications will be sent to the first author via email on Friday, January 27
  • MODIFICATIONS: Submitters may return to the online system to edit abstracts, add co-authors, revise information, correct typographical errors, insert tables, graphics, or delete a submission at any time before the submission deadline. The site will close at 5pm ET, Friday, December 16, at which time no additional revisions will be accepted.
  • WITHDRAWALS: To withdraw an accepted abstract, send a written request to Jennifer Pendo by Monday, April 3. After this date, withdrawals will still be accepted but abstracts may appear in pre-printed annual meeting materials. Withdrawal of an accepted abstract after this date or failure to present an accepted abstract may result in disqualification of the first author and all co-authors from presenting an abstract at the next ACR Annual Meeting.
  • REGISTRATION AND TRAVEL: The first authors of accepted abstracts must register for and attend the meeting. Abstract authors are responsible for their registration and travel arrangements. The ACR does not provide honorarium or reimbursement of travel expenses.

Subject Categories

Advocacy, Economics and Health Policy
Advocacy abstracts should pertain to federal and state matters that relate to imaging. These abstracts are NOT intended to target patient-related advocacy efforts regarding patient rights protection.

Economics and Health Policy abstracts should focus on radiology and radiation oncology service areas related to coverage of services; reporting/coding and reimbursement for new, revised and existing services; policy and payment issues related to third-party payers; tracking Medicaid-managed care organizations; and new payment models.

Clinical Education
Clinical Education abstracts should introduce aspects of education theory that improve the way we educate trainees and colleagues. Abstracts focused on clinical radiology (i.e., more traditional abstracts seen at other national radiology meetings) will not be considered for this meeting. 

Informatics and Innovations
Informatics and Innovations abstracts should pertain to one or more of the following areas: 1) electronic medical records (EMRs), 2) picture archiving and communication systems (PACS), 3) interoperability, 4) computer aided detection (CAD), 5) speech-recognition software, 6) enterprise imaging, 7) radiology business analytics and 8) social media.

Leadership abstracts may target any of the following areas: 1) strategic initiatives to help leaders transition to value-based care, 2) operational metrics and processes for optimizing organizational effectiveness, 3) economic drivers catalyzing changes in health care practice, 4) negotiation principles and applications, 5) leadership development, 6) developing a culture of quality and safety, and 7) medical-legal/ethical dilemmas.

Quality and Safety
Quality and Safety abstracts should pertain to one or more of the following areas: 1) patient safety (including radiation dose optimization), 2) MRI safety, 3) contrast media use, 4) diagnostic or breast imaging accreditation and centers of excellence programs, 5) implementation of evidence-based radiology guidelines, practice parameters, technical standards, appropriateness criteria, or appropriate use criteria, 6) quality management in radiology practice (including quality improvement tools and methods, such as use of data registries and structured reporting), and 7) building a quality infrastructure.

Author Requirements

The first author must:

  • Obtain approval in advance from all co-authors before placing their names on the abstract. Submission of an abstract denotes that co-authors as well as authors have read the abstract, take responsibility for its content, and approve that their names appear on the abstract. Failure to obtain approval from all authors will result in immediate rejection of the abstract.
  • Limit the number of authors to ten
  • Include the affiliation of every author; spell out the institutions completely and capitalize the first letter of each proper name (for example, Johns Hopkins University, University of Texas Southwestern Medical Center)
  • Include a concise statement of the research under the Purpose tab and within the Overall Objectives for the abstract. Define all concepts and abbreviations at first use.
  • Describe experimental methods briefly (including relevant numbers of patients)
  • Ensure that patient confidentiality is protected according to HIPAA regulations
  • Describe specific findings and analysis of data; promises such as “to be completed” will not be considered
  • Include specific conclusions, with supporting statistical analyses, when appropriate; concluding statements such as “results will be discussed” will not be considered
  • Refrain from submitting multiple abstracts on overlapping facets of the same project unless each abstract has important, novel information and clearly stands on its own. Repetitive abstracts will be rejected.
  • Remove brand names from the abstract title or body; use generic terms if referencing a medical device and/or pharmaceutical product
  • Refrain from submitting an abstract already presented at other meetings. Previously presented abstracts that include updated information with significant new implications will be considered.
  • Resolve any issues relating to patent matters before submitting the abstract
  • Agree to the ACR embargo and copyright policies
  • Disclose any financial interest in accordance with the ACR disclosure of financial relationships policy. List any financial interests, assistance, or relationships with companies, supporters, or commercial products related to the research (for example, research support, grants, sponsors, stockholders, etc.). Each co-author must complete his or her own financial disclosure and attestation form. NOTE: ACR will not provide continuing medical education credit for ePosters; however, financial disclosures are still required.
  • Ensure that the first author of an abstract does NOT have a financial interest in the scientific content of the abstract. If the first author has a conflict of interest related to the content, choose a co-author who does not have a relationship to the commercial interests related to the content to be the first author.
  • Be prepared to register for and attend the meeting. First authors of accepted abstracts are required to register and attend the meeting. ACR does not provide honorarium or travel reimbursement.
  • Inform all co-authors of the status of the submitted abstract. The first author will receive all notifications and communications related to the accepted abstract(s) and is responsible for informing all co-authors of acceptance at the meeting

Formatting Your Abstract

  • In accordance with HIPAA regulations, patient confidentiality must be protected. Names, dates of scans, birth dates, ages, medical record numbers, zip codes, and identities must not be included in the abstract or on images and graphs.
  • The maximum character limit of the abstract is 2,200 including spaces; spaces do count towards the character limit  
  • Use simple fonts
  • Italics, underline, bold, superscript and subscript formatting, Greek characters (both upper and lowercase), scientific characters, charts, tables, and graphs are accepted in the body of the abstract only — do not use these in the title of the abstract
  • The abstract may contain one small image and one graph. A minimum resolution of 500 dpi and format of tiff, jpg, or esp is required.   
  • A maximum of ten authors may be listed on each abstract. Apply authorship credit only if you meet all three of criteria below. Each author must make substantial contributions to:
    • Concept and design, or analysis and interpretation of data, and
    • Drafting the abstract or revising it critically for important intellectual content, and
    • Final approval of the version to be submitted/published
  • You may type or copy and paste the text of your abstract from a word processing document or clipboard directly into the online abstract box
  • All required fields must be complete or the submission will be marked incomplete. Abstract submissions with an “incomplete” status cannot be processed.
  • Do not send multiple submissions of the same abstract. Duplicate abstracts will be rejected. Be sure to combine all new information into one abstract.
  • Always keep an original copy of your submitted abstract
  • Always proofread your abstract; accepted abstracts will be published exactly as submitted
  • ePosters must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. ACR reserves the right to replace proprietary names with generic names.  
  • To keep the review process blind, fair and objective, do not include institution names in the title or body of the abstract. Alternative language that may be used is "at an institution" or "a multi-institution" study, etc. This does not apply to cooperative research group names such as RTOG, SWOG, ECOG, etc

Gold Merit Awards

ACR will present up to 5 Gold Merit Awards to the highest scored abstract in each category. Abstract scores are based on quality of research and content, accuracy of research/content and interpretations, and relevance to the meeting.

The top scoring abstract in each of the 5 pathways will receive a $400 travel award. The recipient must complete a W-9 tax form and attend the meeting to claim the award in person. If the author does not attend the meeting, the award is forfeited.

All accepted abstracts will be considered for the Gold Merit Awards.

Disclosure of Financial Relationships Policy and Resolution

The American College of Radiology (ACR) is accredited by the Accreditation Council on Continuing Medical Education (ACCME) to sponsor continuing medical education activities for physicians. 

The ACR Financial Disclosure Policy: In compliance with ACCME requirements and guidelines, the ACR has developed a policy for review and disclosure of financial interests, and a method of resolution if a conflict does exist. The ACR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve this integrity and objectivity, all individuals participating as planners, presenters, authors, moderators and evaluators in an ACR educational activity or an activity jointly sponsored by the ACR must appropriately disclose any financial relationship with a commercial organization that may have an interest in the content of the educational activity.

All first and co-authors will be required to complete a disclosure form and attest that the statements in the form are accurate and the abstract complies with privacy and data security standards of the U.S. Department of Health and Human Services Health Insurance Portability and Accountability Act of 1996 (HIPAA). Authors must attest that the abstract will adhere to all ACCME Criteria and Standards for Commercial Support. 

ACR Resolution Mechanism: The ACCME requires all accredited providers of CME to have a mechanism in place for identifying and resolving potential financial conflicts of interest prior to the educational offering. The ACCME considers financial relationships to create actual conflicts of interest “when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest.” A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACR requires that the first author of an abstract does NOT have a financial interest in the scientific content of the abstract. If the first author has a conflict of interest related to the content, choose a co-author who does not have a relationship to the commercial interests related to the content to attend the meeting and answer attendee questions.

Originality and Copyright Policy

Abstracts submitted to the ACR Annual Meeting must be original and have no prior ownership or copyright restrictions. By submitting an abstract to the ACR Annual Meeting, the first author and co-authors:

  • Attest that there are no third-party ownership or copyright restrictions; and
  • Give ACR permission to record, reproduce, and publish the abstract and findings in the meeting program, on the ACR website, in any additional proceedings related to the meeting, and in ACR online and print publications; and
  • Transfer copyright ownership of the accepted abstract to ACR. All authors of accepted abstracts are automatically issued a license to allow the reuse of their abstracts at the time they transfer copyright ownership of their abstracts to ACR. Authors need not contact the ACR to request permission to repurpose or build upon the work published in their abstracts. This right only applies to abstract authors and does not preclude the need to obtain permission from non-authors to republish abstracts

Hold Harmless Clause

Abstract author(s) agrees to bear full responsibility for any claims, damages or losses that may occur because of any acts or omissions made during his or her presentation. The ACR will have no liability for those acts or omissions. However, abstract author(s) will not have any such responsibility if the ACR is proven to be solely negligent.

Embargo Policy

All accepted abstracts submitted to the ACR Annual Meeting are embargoed until the first day of the meeting, unless otherwise noted by ACR. The first author is responsible for conveying this information to all co-authors. For questions regarding the embargo policy, please contact Jennifer Pendo, Senior Program Manager, ACR Annual Meeting.

Health Insurance Portability and Accountability Act of 1996 (HIPAA)

The ACR requires that the content of all education presentations submitted to ACR meetings is in compliance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the U.S. Department of Health and Human Services regulations implementing this act. To comply with HIPAA regulations, patient confidentiality must be maintained in all education presentations, including ePoster sessions.

Members of the ACR Program Committee, Planning Committee, and Education and Meetings staff will monitor presentations to identify ways to improve overall presentation quality and HIPAA compliance throughout the meeting.

Patient confidentiality must be protected. Names, dates of scans, birth dates, ages, Zip codes, medical record numbers, and identities must not be included on slides, images, or posters that are submitted to ACR. A complete list of identifiers can be found under the "Safe Harbor method” on the Health and Human Services website.

Submit Your Abstract


Questions regarding the online submission process may be directed to the ACR Education Department at or 703-648-0684.

Due to circumstances beyond ACR control, information provided on this page is subject to change.